Short-term fasting could boost chemo response in ovarian cancer, study suggests

medicalxpress - A simple change in meal timing may help improve outcomes for women with the most common and aggressive form of ovarian cancer, a new study suggests.

AI Summary: ASCO‑presented research indicates short‑term fasting around chemotherapy cycles can enhance response in high‑grade serous ovarian cancer versus a regular diet, altering tumor biology to increase chemosensitivity. The findings suggest a low‑cost adjunct to standard treatment, though real‑world feasibility and longer‑term benefits require larger trials — fasting as a potential therapeutic booster, not a fad.